ATE529096T1 - Pharmazeutische zusammensetzungen mit bradykinin- antagonisten und hyaluronsäure sowie anwendungen davon - Google Patents

Pharmazeutische zusammensetzungen mit bradykinin- antagonisten und hyaluronsäure sowie anwendungen davon

Info

Publication number: ATE529096T1
Authority: AT; Austria
Prior art keywords: pharmaceutical compositions; hyaluronic acid; compositions containing; bradykinin antagonists; containing bradykinin
Prior art date: 2007-11-23

Application number

AT08853047T

Other languages

English (en)

Inventor

Carlo Maggi

Sandro Giuliani

Laura Quartara

Original Assignee

Luso Farmaco Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-11-23

Filing date

2008-11-10

Publication date

2011-11-15

2008-11-10 Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst

2011-11-15 Application granted granted Critical

2011-11-15 Publication of ATE529096T1 publication Critical patent/ATE529096T1/de

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
239000003152 bradykinin antagonist Substances 0.000 title 1
229920002674 hyaluronan Polymers 0.000 title 1
229960003160 hyaluronic acid Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Neurosurgery (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

AT08853047T 2007-11-23 2008-11-10 Pharmazeutische zusammensetzungen mit bradykinin- antagonisten und hyaluronsäure sowie anwendungen davon ATE529096T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT002225A ITMI20072225A1 (it)	2007-11-23	2007-11-23	"composizioni farmaceutiche a base di antagonisti della bradichinina ed acido ialuronico e loro uso"
PCT/EP2008/009451 WO2009065507A2 (en)	2007-11-23	2008-11-10	Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof

Publications (1)

Publication Number	Publication Date
ATE529096T1 true ATE529096T1 (de)	2011-11-15

Family

ID=40314753

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT08853047T ATE529096T1 (de)	2007-11-23	2008-11-10	Pharmazeutische zusammensetzungen mit bradykinin- antagonisten und hyaluronsäure sowie anwendungen davon

Country Status (40)

Country	Link
US (1)	US9101627B2 (de)
EP (1)	EP2222275B1 (de)
JP (1)	JP5383695B2 (de)
KR (1)	KR101585868B1 (de)
CN (1)	CN101868225B (de)
AP (1)	AP2628A (de)
AR (1)	AR069407A1 (de)
AT (1)	ATE529096T1 (de)
AU (1)	AU2008328311B2 (de)
BR (1)	BRPI0820402A2 (de)
CA (1)	CA2706398C (de)
CL (1)	CL2008003475A1 (de)
CO (1)	CO6270301A2 (de)
CR (1)	CR11457A (de)
CY (1)	CY1112134T1 (de)
DK (1)	DK2222275T3 (de)
EA (1)	EA017626B1 (de)
EC (1)	ECSP10010153A (de)
ES (1)	ES2374861T3 (de)
GE (1)	GEP20125602B (de)
HN (1)	HN2010001037A (de)
HR (1)	HRP20110904T1 (de)
IL (1)	IL205860A (de)
IT (1)	ITMI20072225A1 (de)
MA (1)	MA31913B1 (de)
MX (1)	MX2010005484A (de)
MY (1)	MY148685A (de)
NI (1)	NI201000087A (de)
NZ (1)	NZ585514A (de)
PA (1)	PA8804801A1 (de)
PE (1)	PE20091422A1 (de)
PL (1)	PL2222275T3 (de)
PT (1)	PT2222275E (de)
RS (1)	RS52045B (de)
SI (1)	SI2222275T1 (de)
TN (1)	TN2010000215A1 (de)
TW (1)	TWI448292B (de)
UA (1)	UA97867C2 (de)
WO (1)	WO2009065507A2 (de)
ZA (1)	ZA201003586B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL420378A1 (pl) *	2014-05-30	2017-10-23	Nataliia Mykolaivna Derkach	Stabilizowany roztwór na bazie substancji czynnych, sposób otrzymywania stabilizowanego roztworu substancji czynnych, kompozycja farmaceutyczna na bazie stabilizowanego roztworu substancji czynnych (dwa warianty)
CN107106594A (zh) *	2014-12-26	2017-08-29	生化学工业株式会社	改善眼的自觉症状的制剂和方法
WO2020022791A1 (ko)	2018-07-25	2020-01-30	(주)알테오젠	신규 히알루론산 가수분해 효소 변이체 및 이를 포함하는 약제학적 조성물
CN112203642B (zh)	2019-03-25	2025-03-07	阿特根公司	用于皮下注射的包含人透明质酸酶ph20变体和药物的药物组合物
CN121472194A (zh)	2020-01-23	2026-02-06	阿特根公司	具有改善的稳定性的新玻尿酸酶变体及含有其的药物组合物
US11401303B2 (en) *	2020-06-15	2022-08-02	Taian City Qihang Biotechnology Co.	Synthetic peptide BRAP and application in preparation of anti-inflammatory drug for COVID-19 thereof
JP7622088B2 (ja)	2020-08-07	2025-01-27	アルテオジェン・インコーポレイテッド	組換えヒアルロニダーゼの生産方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7635489B2 (en) *	2001-05-18	2009-12-22	Leneau Holdings, Llc	Ingestion of hyaluronic acid for improved joint health
ITMI20021247A1 (it)	2002-06-07	2003-12-09	Menarini Ricerche Spa	Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
ITMI20041963A1 (it) *	2004-10-15	2005-01-15	Luso Farmaco Inst	"antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"

2007
- 2007-11-23 IT IT002225A patent/ITMI20072225A1/it unknown
2008
- 2008-11-07 TW TW097142981A patent/TWI448292B/zh not_active IP Right Cessation
- 2008-11-10 PT PT08853047T patent/PT2222275E/pt unknown
- 2008-11-10 CA CA2706398A patent/CA2706398C/en not_active Expired - Fee Related
- 2008-11-10 RS RS20110524A patent/RS52045B/sr unknown
- 2008-11-10 CN CN2008801169202A patent/CN101868225B/zh not_active Expired - Fee Related
- 2008-11-10 PL PL08853047T patent/PL2222275T3/pl unknown
- 2008-11-10 EP EP08853047A patent/EP2222275B1/de active Active
- 2008-11-10 AP AP2010005265A patent/AP2628A/xx active
- 2008-11-10 UA UAA201006127A patent/UA97867C2/ru unknown
- 2008-11-10 HR HR20110904T patent/HRP20110904T1/hr unknown
- 2008-11-10 DK DK08853047.2T patent/DK2222275T3/da active
- 2008-11-10 SI SI200830475T patent/SI2222275T1/sl unknown
- 2008-11-10 US US12/743,891 patent/US9101627B2/en not_active Expired - Fee Related
- 2008-11-10 BR BRPI0820402-0A patent/BRPI0820402A2/pt not_active IP Right Cessation
- 2008-11-10 KR KR1020107011164A patent/KR101585868B1/ko not_active Expired - Fee Related
- 2008-11-10 MY MYPI2010002358A patent/MY148685A/en unknown
- 2008-11-10 GE GEAP200811807A patent/GEP20125602B/en unknown
- 2008-11-10 MX MX2010005484A patent/MX2010005484A/es active IP Right Grant
- 2008-11-10 ES ES08853047T patent/ES2374861T3/es active Active
- 2008-11-10 NZ NZ585514A patent/NZ585514A/en not_active IP Right Cessation
- 2008-11-10 AU AU2008328311A patent/AU2008328311B2/en not_active Ceased
- 2008-11-10 JP JP2010534395A patent/JP5383695B2/ja not_active Expired - Fee Related
- 2008-11-10 AT AT08853047T patent/ATE529096T1/de active
- 2008-11-10 EA EA201000678A patent/EA017626B1/ru not_active IP Right Cessation
- 2008-11-10 WO PCT/EP2008/009451 patent/WO2009065507A2/en not_active Ceased
- 2008-11-19 PE PE2008001955A patent/PE20091422A1/es not_active Application Discontinuation
- 2008-11-21 AR ARP080105077A patent/AR069407A1/es unknown
- 2008-11-21 PA PA20088804801A patent/PA8804801A1/es unknown
- 2008-11-21 CL CL2008003475A patent/CL2008003475A1/es unknown
2010
- 2010-05-05 EC EC2010010153A patent/ECSP10010153A/es unknown
- 2010-05-06 CO CO10054082A patent/CO6270301A2/es active IP Right Grant
- 2010-05-14 TN TN2010000215A patent/TN2010000215A1/fr unknown
- 2010-05-19 NI NI201000087A patent/NI201000087A/es unknown
- 2010-05-20 IL IL205860A patent/IL205860A/en not_active IP Right Cessation
- 2010-05-20 HN HN2010001037A patent/HN2010001037A/es unknown
- 2010-05-20 ZA ZA2010/03586A patent/ZA201003586B/en unknown
- 2010-05-21 CR CR11457A patent/CR11457A/es unknown
- 2010-06-15 MA MA32913A patent/MA31913B1/fr unknown
2011
- 2011-11-30 CY CY20111101177T patent/CY1112134T1/el unknown

Also Published As

Publication number	Publication date
EA017626B1 (ru)	2013-01-30
HN2010001037A (es)	2012-12-10
PL2222275T3 (pl)	2012-03-30
KR20100096106A (ko)	2010-09-01
IL205860A (en)	2013-01-31
GEP20125602B (en)	2012-08-10
CY1112134T1 (el)	2015-11-04
CN101868225B (zh)	2013-06-12
PE20091422A1 (es)	2009-10-17
TWI448292B (zh)	2014-08-11
DK2222275T3 (da)	2012-01-02
MA31913B1 (fr)	2010-12-01
MX2010005484A (es)	2010-06-07
ECSP10010153A (es)	2010-06-29
CA2706398C (en)	2016-07-05
CR11457A (es)	2010-11-05
JP5383695B2 (ja)	2014-01-08
IL205860A0 (en)	2010-11-30
PA8804801A1 (es)	2009-06-23
WO2009065507A3 (en)	2009-09-03
CO6270301A2 (es)	2011-04-20
NZ585514A (en)	2012-01-12
TN2010000215A1 (en)	2011-11-11
SI2222275T1 (sl)	2012-01-31
PT2222275E (pt)	2012-01-16
NI201000087A (es)	2011-07-18
AP2010005265A0 (en)	2010-06-30
RS52045B (sr)	2012-04-30
WO2009065507A2 (en)	2009-05-28
CA2706398A1 (en)	2009-05-28
AU2008328311B2 (en)	2013-02-28
AU2008328311A1 (en)	2009-05-28
TW200927151A (en)	2009-07-01
BRPI0820402A2 (pt)	2015-05-19
ES2374861T3 (es)	2012-02-22
MY148685A (en)	2013-05-31
CN101868225A (zh)	2010-10-20
AP2628A (en)	2013-03-26
ITMI20072225A1 (it)	2009-05-24
US20100292156A1 (en)	2010-11-18
AR069407A1 (es)	2010-01-20
US9101627B2 (en)	2015-08-11
KR101585868B1 (ko)	2016-01-22
UA97867C2 (ru)	2012-03-26
HRP20110904T1 (hr)	2011-12-31
ZA201003586B (en)	2011-08-31
JP2011504473A (ja)	2011-02-10
HK1149714A1 (en)	2011-10-14
CL2008003475A1 (es)	2009-03-27
EP2222275A2 (de)	2010-09-01
EA201000678A1 (ru)	2010-12-30
EP2222275B1 (de)	2011-10-19

Legal Events

Date

Code

Title

Description

2012-05-15

UEP

Publication of translation of european patent specification

Ref document number: 2222275

Country of ref document: EP

Publication	Publication Date	Title
IL275854A (en)	2020-08-31	Pharmaceutical composition and its administration
BRPI0923836A2 (pt)	2015-07-21	Composições farmacêuticas orais contendo opióide e métodos
EP3861986C0 (de)	2025-11-26	Pharmazeutische zusammensetzungen mit polypeptiden und zugehörige abgabeverfahren
ATE542815T1 (de)	2012-02-15	Kokristalle und pharmazeutische zusammensetzungen damit
DE602007010797D1 (de)	2011-01-05	Pharmazeutische zusammensetzungen mit rosuvastatin-calcium
DK2346495T4 (da)	2023-08-28	Farmaceutisk formulering 514
BRPI0810928A2 (pt)	2019-09-24	"composição farmacêutica"
LT2606874T (lt)	2016-12-12	Naujos kosmetinės ir/arba farmacinės kompozicijos ir jų panaudojimas
EP2056835A4 (de)	2013-01-30	Pharmazeutische zusammensetzungen und ihre verwendungen
IL215799A (en)	2014-11-30	Quinazolone compounds, pharmaceuticals containing them and their uses
LT2493474T (lt)	2019-10-10	Būdai ir kompozicijos prolonguotam vaistų įvedimui
EP2451274A4 (de)	2014-04-02	Pharmazeutische zusammensetzungen
ATE493119T1 (de)	2011-01-15	Pharmazeutische zusammensetzung
BRPI0908596A2 (pt)	2015-09-15	formulação e composição farmacêutica de liberação prolongada
BRPI0821115A2 (pt)	2015-06-16	Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
PL2154966T3 (pl)	2014-03-31	Benzoimidazole i ich kompozycje farmaceutyczne
EP2474522A4 (de)	2013-03-20	Agomelatin und pharmazeutische zusammensetzungen daraus
BRPI0807078A2 (pt)	2014-04-08	Composto, e, formulação farmacêutica
BRPI1009392A2 (pt)	2016-03-08	"formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
EP2643009A4 (de)	2015-04-01	Zusammensetzung zur freisetzung biologisch abbaubarer wirkstoffe
ATE530546T1 (de)	2011-11-15	Kokristalle und pharmazeutische zusammensetzungen damit
BRPI1006666A2 (pt)	2016-04-19	" composição farmacêutica e uso de uma composição farmacêutica"
DE602008005137D1 (de)	2011-04-07	Chinolonverbindung und pharmazeutische zusammensetzung
DK2222275T3 (da)	2012-01-02	Farmaceutiske sammensætninger indeholdende bradykininantagonister og hyaluronsyre og anvendelser deraf
BR112012016736A2 (pt)	2016-12-13	composição , formulação farmacêutica e uso da composição"